Hopes of a New Treatment Approach for Paralysis
Paralysis in the form of paraplegia and quadriplegia is usually the result of traumatic spinal cord injuries, but can also be caused by tumors. When the spinal cord is cut off, information sent by the brain can no longer be transmitted to the limbs. Biological processes such as programmed cell death, or apoptosis, take place after the actual moment of injury of the nerve cords and lead to further destruction of the damaged tissue and thus to permanent paralysis.
Dr. Ana Martin-Villalba and collaborators at the Immunogenetics Division headed by Professor Dr. Peter Krammer describe in the latest issue of the science journal Nature Medicine how blockage of a key molecule of apoptosis restores the ability of coordinated movement of paralyzed limbs. Using specific antibodies, the investigators blocked a protein called CD95 L which triggers a suicide cascade in cells carrying the specific receptor protein CD95.
The experiments showed that mice treated with antibodies after selective spinal cord injuries performed significantly better in special skill tests than the control animals. In addition, tissue sections of the treated animals revealed newly growing nerve fibers beyond the place of injury. Treatment with antibodies also prevented oligodendrocytes from dying - cells that insulate the cord-like nerve fibers and thus facilitate signal transmission.
Brain injuries and spinal cord injuries are the leading causes of deaths and severe disabilities in individuals under 40 years of age. In the future, specific blockage of apoptosis may become a way of preventing life-long paralysis by protecting injured nerves from further destruction.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous